Search Results - "SATO, Atsuhisa"

Refine Results
  1. 1

    Does the temporary decrease in the estimated glomerular filtration rate (eGFR) after initiation of mineralocorticoid receptor (MR) antagonist treatment lead to a long-term renal protective effect? by Sato, Atsuhisa

    Published in Hypertension research (01-12-2019)
    “…Recently, deleterious effects of aldosterone on the kidney via mineralocorticoid receptors (MRs) have been noted. MR antagonists have been reported to show…”
    Get full text
    Journal Article
  2. 2

    The necessity and effectiveness of mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy by Sato, Atsuhisa

    Published in Hypertension research (01-06-2015)
    “…Diabetes mellitus is a major cause of chronic kidney disease (CKD), and diabetic nephropathy is the most common primary disease necessitating dialysis…”
    Get full text
    Journal Article
  3. 3

    Clinical effect of nonsteroidal mineralocorticoid receptor (MR) antagonists in the treatment of diabetic kidney disease: expectations as a new therapeutic strategy by Sato, Atsuhisa, Nishimoto, Mitsuhiro

    Published in Hypertension research (01-08-2022)
    “…Diabetes mellitus is the main cause of chronic kidney disease (CKD) in Japan and worldwide. Although angiotensin-converting enzyme (ACE) inhibitors and…”
    Get full text
    Journal Article
  4. 4

    Mineralocorticoid receptor antagonists: their use and differentiation in Japan by Sato, Atsuhisa

    Published in Hypertension research (01-03-2013)
    “…In the presence of salt, aldosterone causes hypertension and organ damage via the mineralocorticoid receptor (MR) through various mechanisms. MR antagonists…”
    Get full text
    Journal Article
  5. 5

    Effect of aldosterone breakthrough on albuminuria during treatment with a direct renin inhibitor and combined effect with a mineralocorticoid receptor antagonist by Sato, Atsuhisa, Fukuda, Seiichi

    Published in Hypertension research (01-10-2013)
    “…We have reported observing aldosterone breakthrough in the course of relatively long-term treatment with renin-angiotensin (RA) system inhibitors, where the…”
    Get full text
    Journal Article
  6. 6

    Aldosterone-Induced Organ Damage: Plasma Aldosterone Level and Inappropriate Salt Status by SATO, Atsuhisa, SARUTA, Takao

    Published in Hypertension Research (01-05-2004)
    “…In recent years, it has been clarified that aldosterone can directly damage various organs, such as the heart, blood vessel, and kidneys, via non-epithelial…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Combination Therapy with Aldosterone Blockade and Renin-Angiotensin Inhibitors Confers Organ Protection by Sato, Atsuhisa, Saruta, Takao, Funder, John W

    Published in Hypertension research (01-04-2006)
    “…There is increasing evidence that aldosterone exerts major adverse cardiovascular effects through classical mineralocorticoid receptors (MR) in nonepithelial…”
    Get full text
    Journal Article
  9. 9

    Aldosterone Breakthrough During Angiotensin II Receptor Antagonist Therapy in Stroke-Prone Spontaneously Hypertensive Rats by Naruse, Mitsuhide, Tanabe, Akiyo, Sato, Atsuhisa, Takagi, Sachiko, Tsuchiya, Ken, Imaki, Toshihiro, Takano, Kazue

    Published in Hypertension (Dallas, Tex. 1979) (01-07-2002)
    “…Aldosterone breakthrough during ACE inhibitor therapy has been reported. This study investigates changes in plasma aldosterone concentration (PAC) and its…”
    Get full text
    Journal Article
  10. 10

    Relative Long-Term Effects of Spironolactone in Conjunction with an Angiotensin-Converting Enzyme Inhibitor on Left Ventricular Mass and Diastolic Function in Patients with Essential Hypertension by SATO, Atsuhisa, HAYASHI, Matsuhiko, SARUTA, Takao

    Published in Hypertension Research (01-11-2002)
    “…It has been reported that treatment with an angiotensin-converting enzyme (ACE) inhibitor is not adequate to suppress aldosterone, and we previously…”
    Get full text
    Journal Article
  11. 11
  12. 12

    A prospective study of frequency and characteristics of cough during ACE inhibitor treatment by Sato, Atsuhisa, Fukuda, Seiichi

    “…Angiotensin converting enzyme (ACE) inhibitors are reportedly effective, and positively indicated in patients with chronic heart failure with decreased…”
    Get full text
    Journal Article
  13. 13

    Effects of Spironolactone and Angiotensin-Converting Enzyme Inhibitor on Left Ventricular Hypertrophy In Patients with Essential Hypertension by Sato, Atsuhisa, Suzuki, Yoshiyuki, Saruta, Takao

    Published in Hypertension Research (01-03-1999)
    “…There is increasing evidence for important cardiovascular effects of aldosterone via classical mineralocorticoid receptors in the heart. Administration of…”
    Get full text
    Journal Article
  14. 14

    High Serum Level of Procollagen Type III Amino-Terminal Peptide Contributes to the Efficacy of Spironolactone and Angiotensin-Converting Enzyme Inhibitor Therapy on Left Ventricular Hypertrophy in Essential Hypertensive Patients by SATO, Atsuhisa, TAKANE, Hiroshi, SARUTA, Takao

    Published in Hypertension Research (2001)
    “…We recently demonstrated that spironolactone may have beneficial effects on left ventricular hypertrophy in selected patients with essential hypertension…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Adrenomedullin Stimulates cAMP Accumulation and Inhibits Atrial Natriuretic Peptide Gene Expression in Cardiomyocytes by Sato, Atsuhisa, Canny, Benedict J., Autelitano, Dominic J.

    “…Adrenomedullin (ADM) is a novel vasodilating and natriuretic peptide which may play an important role in cardiovascular regulation. In neonatal cardiomyocyte…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Aldosterone antagonist facilitates the cardioprotective effects of angiotensin receptor blockers in hypertensive rats by Tanabe, Akiyo, Naruse, Mitsuhide, Hara, Yoshiko, Sato, Atsuhisa, Tsuchiya, Ken, Nishikawa, Toshio, Imaki, Toshihiro, Takano, Kazue

    Published in Journal of hypertension (01-05-2004)
    “…Background There is increasing evidence to support the importance of blocking aldosterone to prevent target-organ damage in hypertension. We recently…”
    Get full text
    Journal Article
  19. 19

    Effect of Combination Therapy of Angiotensin-Converting Enzyme Inhibitor plus Calcium Channel Blocker on Urinary Albumin Excretion in Hypertensive Microalubuminuric Patients with Type II Diabetes by SHIGIHARA, Toshikatsu, SATO, Atsuhisa, HAYASHI, Koichi, SARUTA, Takao

    Published in Hypertension Research (2000)
    “…It has been demonstrated that antihypertensive treatment of hypertensive diabetic patients is quite effective in preventing macrovascular and microvascular…”
    Get full text
    Journal Article
  20. 20

    Plasma Aldosterone Concentrations Are Not Related to the Degree of Angiotensin-Converting Enzyme Inhibition in Essential Hypertensive Patients by SATO, Atsuhisa, SUZUKI, Yoshiyuki, SHIBATA, Hirotaka, SARUTA, Takao

    Published in Hypertension Research (2000)
    “…There is increasing evidence of important cardiovascular effects of aldosterone via classical mineralocorticoid receptors in the heart. Aldosterone plus excess…”
    Get full text
    Journal Article